Universe Pharmaceuticals (UPC) Other Non-Current Assets (2022 - 2024)

Universe Pharmaceuticals (UPC) has 3 years of Other Non-Current Assets data on file, last reported at -$96326.0 in Q1 2024.

• For the quarter ending Q1 2024, Other Non-Current Assets changed N/A year-over-year to -$96326.0; the trailing twelve-month figure through Mar 2024 stood at -$96326.0 (changed N/A YoY), and the FY2023 full-year result was $35864.0, down 98.53% from the prior year.
• Other Non-Current Assets eased to -$96326.0 in Q1 2024, from $35864.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q3 2022 to a low of -$96326.0 in Q1 2024.
• A 3-year average of $793024.3 and a median of $35864.0 in 2023 frame the typical range for Other Non-Current Assets.
• Peak annual rise in Other Non-Current Assets reached 98.53% in 2023, while the deepest fall reached 98.53% in 2023.
• Tracing UPC's Other Non-Current Assets over 3 years: stood at $2.4 million in 2022, then sank by 98.53% to $35864.0 in 2023, then sank by 368.59% to -$96326.0 in 2024.
• Business Quant data shows UPC's Other Non-Current Assets at -$96326.0 in Q1 2024, $35864.0 in Q3 2023, and $2.4 million in Q3 2022.